Prerna Infrabuild Ltd.

Price on BSE   21 Oct,15:29 LIVE
22.13
-0.94
(-4.07%)

© 2026 Rediff.com
  • Volume :
  • 11,982.00
  • Prev Close :
  • 23.07
  • Day's H/L (Rs.) :
  • 23.42 - 22.00
  • 52wk H/L (Rs.) :
  • 32.99 - 19.03
  • Mkt Cap (Rs. Cr) :
  • 13.50
Prerna Infrabuild Ltd. is not listed on NSE

© 2026 Rediff.com
Report Card - Prerna Infrabuild Ltd.
PE Ratios
25.76
EPS (Rs.)
0.90
Sales (Rs. Cr)
1.53
Face Value (Rs.)
10
Net Profit Margin(%)
71.43
Last Bonus
-
Last Dividend(%)
7
Return on Average Equity
3.06

News for Infrastructure - General

Stock Markets Fall 2nd Day; Jio IPO Oversubscribed
Indian benchmark indices Sensex and Nifty fell for a second consecutive day due to selling in banking and financial stocks, high crude oil prices, and firm US bond yields. Meanwhile, Jio Platforms'...
Oct 21, 2026 18:04
India a Top Market for William Grant & Sons, Eyes Top 5
William Grant & Sons sees India as a rapidly growing market, projected to enter its top five global markets in 5-10 years, driven by premiumization and FTA.
Oct 21, 2026 18:01
Agrivoltaics Must Not Cut Farm Output: Agri Minister
Union Agriculture Minister Shivraj Singh Chouhan backs agrivoltaics for dual land use but warns against reduced crop production, urging practical policy.
Oct 21, 2026 18:00
Adani Green Q2 Profit Jumps 16% to Rs 747 Cr on Strong Growth
Adani Green Energy reports 16% Q2 net profit rise to Rs 747 cr, driven by 39% revenue growth & significant renewable capacity expansion, including world's largest BESS.
Oct 21, 2026 17:55
Jamnagar Refinery: US Influence vs. Reliance's Crude Economics
US seeks to influence Reliance's Jamnagar refinery for Venezuelan crude. Economics will largely shape Reliance's crude choices, balancing geopolitics with profit.
Oct 21, 2026 17:50

More News »

Top News

IGI Q2 PAT Surges 43% to Rs 185.8 Cr on Strong Demand
IGI reports a 43.14% PAT surge to Rs 185.8 Cr in Q2 FY27, with revenue up 31%. Strong demand for natural & lab-grown diamonds drives growth.
Oct 21, 2026 18:09
Nucelion & VeGen Bio Partner for Cell Therapy Innovation
Nucelion Therapeutics and VeGen Bio collaborate to manufacture advanced cell therapies like CAR-T for multiple myeloma in India, aiming for affordability and global standards.
Oct 21, 2026 18:08
HDFC Bank Probes Data Leak by Senior Executives
HDFC Bank launches an internal probe into alleged confidential data leaks by two senior executives. The investigation comes amid leadership changes and past governance concerns.
Oct 21, 2026 18:07
Stock Markets Fall 2nd Day; Jio IPO Oversubscribed
Indian benchmark indices Sensex and Nifty fell for a second consecutive day due to selling in banking and financial stocks, high crude oil prices, and firm US bond yields. Meanwhile, Jio Platforms'...
Oct 21, 2026 18:04
India a Top Market for William Grant & Sons, Eyes Top 5
William Grant & Sons sees India as a rapidly growing market, projected to enter its top five global markets in 5-10 years, driven by premiumization and FTA.
Oct 21, 2026 18:01

More Top News »